Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants.
about
Dopaminergic and serotonergic drug use: a nationwide register-based study of over 1,300,000 older peopleBridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT projectUse of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis.Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.Relationship between use of antidepressants and risk of fractures: a meta-analysis.Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome.Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem.Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Antidepressant use, depressive symptoms, and incident frailty in women aged 65 and older from the Women's Health Initiative Observational Study.Spinal Bone Texture Assessed by Trabecular Bone Score in Adolescent Girls With Anorexia Nervosa.SSRIs: bad to the bone?Telephone-based care management for older adults initiated on psychotropic medication.Use of antidepressant medications and risk of fracture in older womenAntidepressants and fracture risk in older adults: a comparative safety analysis.Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and doseDrug-induced osteoporosis: from Fuller Albright to aromatase inhibitors.Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fracture.Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture.ACTIVEDEP: a randomised, controlled trial of a home-based exercise intervention to alleviate depression in middle-aged and older adults.Older adults recently started on psychotropic medication: where are the symptoms?Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey.Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies.
P2860
Q28476572-87945C96-6F43-4764-9962-9710CDB6B4AEQ33851671-DE41AA09-C2BA-4D41-A09F-12D7287B864EQ34132829-B92C141D-684A-436E-9162-EF8AD59F2659Q34214948-E5DBB131-9D6C-4D97-8628-C63FDAC531E8Q34277620-F870B5FF-75E8-48C1-AC2C-09B654449072Q34432269-224A36D5-19CC-4A94-809C-5B4BA486D962Q34634559-AD85A8E8-0E1E-4973-BF15-AB2468D7881FQ34863279-5B4A6485-0ECB-4BF2-8C90-7C1392DB5D2EQ35754726-C5345BAD-4CEE-4414-B9F8-3FEB6562BB1EQ35965643-6F6F3E18-80C2-4931-BA75-BFA405CB2512Q36060443-43A1E53F-1BFB-460C-B951-5190CED0157CQ36235126-E038AD5A-22AA-4790-96F6-194772CC46A4Q36445891-A43CC029-4F98-4199-8770-15AAB252A402Q36526151-D8E0DA3B-38D7-40A0-A790-AFCC26F35DE7Q36817545-4C388AA5-765C-4EC1-B193-AE8FF1ADF001Q36855935-E997C7EC-87D2-4CFF-96A3-571098E5D6BFQ38612952-2FE8FDC0-F67B-4818-8EC5-5519C5610808Q39869508-6CB7115D-49B5-4034-BA02-DB436B4A679EQ40781394-15E9C0F3-D57C-4186-AFE9-F7E0FEA34470Q40821461-3AFA29D4-5AE8-46F2-9A39-52D2BE304F40Q46259197-46759863-61A8-4114-8D49-E29704E3779EQ48234767-FBC4D515-666E-4CFC-950D-6CE93BC5EFB3Q48372273-8CA99465-B0E7-4AF5-87E8-D538322DCF09Q48576448-5727F982-7782-4483-B855-24C77A645D0C
P2860
Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of fractures with selecti ...... or tricyclic antidepressants.
@en
Risk of fractures with selecti ...... or tricyclic antidepressants.
@nl
type
label
Risk of fractures with selecti ...... or tricyclic antidepressants.
@en
Risk of fractures with selecti ...... or tricyclic antidepressants.
@nl
prefLabel
Risk of fractures with selecti ...... or tricyclic antidepressants.
@en
Risk of fractures with selecti ...... or tricyclic antidepressants.
@nl
P2860
P356
P1476
Risk of fractures with selecti ...... or tricyclic antidepressants.
@en
P2093
Enma Rosero
Regina Ginzburg
P2860
P304
P356
10.1345/APH.1L264
P407
P577
2008-12-30T00:00:00Z